Drug Type Autologous CAR-T |
Synonyms AVA 011 |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD22 inhibitors(CD22 inhibitors), Gene transference(Gene transference) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Hodgkin Lymphoma | Preclinical | United States | 08 May 2020 | |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Preclinical | United States | 08 May 2020 |





